Literature DB >> 8938167

Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?

A Robert1, O Chazouillères.   

Abstract

Prothrombin time (PT) is a universal indicator of liver disease severity. However, variability in thromboplastin reagents leads to large interlaboratory differences in PT results. The aim of this study was to determine whether the use of the international normalized ratio (INR) or other modes of expression might achieve PT standardization in patients with liver failure. PT was measured with seven thromboplastin reagents with different sensitivities in plasmas from 27 patients with miscellaneous chronic and acute liver failure and, as a control population, 29 patients on oral anticoagulation therapy. PT was expressed in seconds, ratio, activity percentage, and INR. In patients with liver failure, only activity percentage expression eliminated variability in PT results obtained with the seven thromboplastins while INR, seconds, and ratio values remained significantly different (P < .01). In patients on oral anticoagulant therapy, only INR normalized PT results. We conclude that, in patients with liver failure, INR fails to yield a PT expression independent of the thromboplastin used and only activity percentage expression may provide a common international scale of PT reporting.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938167     DOI: 10.1053/jhep.1996.v24.pm0008938167

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  21 in total

1.  Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related?

Authors:  Vinay Sundaram; Abdullah M S Al-Osaimi; Jason J Lewis; Ton Lisman; Stephen H Caldwell
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

2.  4 Plasma for Therapeutic Use.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

3.  Preoperative INR and postoperative major bleeding and mortality: A retrospective cohort study.

Authors:  Hani Tamim; Mohamad Habbal; Antoine Saliba; Khaled Musallam; Muhyeddine Al-Taki; Jamal Hoballah; Sarah Jamali; Ali Taher
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

4.  Predicting short-term mortality and long-term survival for hospitalized US patients with alcoholic hepatitis.

Authors:  Jennifer A Cuthbert; Sami Arslanlar; Jay Yepuri; Marc Montrose; Chul W Ahn; Jessica P Shah
Journal:  Dig Dis Sci       Date:  2014-01-21       Impact factor: 3.199

5.  Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens.

Authors:  M Schmid; A Kreil; W Jessner; M Homoncik; C Datz; A Gangl; P Ferenci; M Peck-Radosavljevic
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 6.  Venous thromboembolism in cirrhosis.

Authors:  Zhineng J Yang; Karen A Costa; Enrico M Novelli; Roy E Smith
Journal:  Clin Appl Thromb Hemost       Date:  2012-10-17       Impact factor: 2.389

7.  Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies.

Authors:  John D Roberson Ii; Andrew M McDonald; Craig J Baden; Chee Paul Lin; Rojymon Jacob; Omer L Burnett Iii
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

8.  Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.

Authors:  B Angermayr; M Cejna; F Karnel; M Gschwantler; F Koenig; J Pidlich; H Mendel; L Pichler; M Wichlas; A Kreil; M Schmid; A Ferlitsch; E Lipinski; H Brunner; J Lammer; P Ferenci; A Gangl; M Peck-Radosavljevic
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

9.  The coagulopathy of acute liver failure and implications for intracranial pressure monitoring.

Authors:  Santiago J Munoz; K Rajender Reddy; William Lee
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

10.  Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.

Authors:  Daniel Gotthardt; Karl Heinz Weiss; Melanie Baumgärtner; Alexandra Zahn; Wolfgang Stremmel; Jan Schmidt; Thomas Bruckner; Peter Sauer
Journal:  BMC Gastroenterol       Date:  2009-09-25       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.